NILO Therapeutics is a biotechnology and therapeutics company.
NILO Therapeutics has raised $101.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
NILO Therapeutics's investors include Lux Capital, Bill & Melinda Gates Foundation, DCVC Bio, The Column Group, Alexandria Venture Investments.
NILO Therapeutics is headquartered in New York, United States.
NILO Therapeutics is a biotechnology and therapeutics company.
NILO Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NILO Therapeutics — Funding & Investors." VCBacked, October 8, 2025, https://www.vcbacked.co/company/nilo-therapeutics. Accessed July 19, 2026.
VCBacked. (2025). NILO Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/nilo-therapeutics
{{cite web |title=NILO Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nilo-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated